Cellyan Biotechnology regains compliance with Nasdaq minimum bid price requirement
HKPD•Cellyan Biotechnology regained compliance with Nasdaq’s minimum bid price requirement on November 13, 2026, after its Class A ordinary shares closed at or above $1 for 14 consecutive business days.
1. Compliance restored
Cellyan Biotechnology said it regained compliance with Nasdaq’s minimum bid price requirement on November 13, 2026, closing the listing compliance matter. Its Class A ordinary shares closed at or above $1 for 14 consecutive business days from October 26 through November 12.




